"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"CR Intrinsic Investors","SAC Capital","$601,747,463","$0","$601,747,463","2013","20130315","financial offenses","investor protection violation","securities issuance or trading violation","Stamford, Conn.-based hedge fund advisory firm CR Intrinsic Investors, an affiliate of S.A.C. Capital, agreed to pay more than $600 million to settle SEC charges that it participated in an insider trading scheme involving a clinical trial for an Alzheimer's drug being jointly developed by two pharmaceutical companies.","federal","agency action","Securities and Exchange Commission","civil","","","","","","","","","","","","USA","Connecticut","out of business","","financial services","hedge fund","https://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171513308",""
"SAC Capital","SAC Capital","$1,800,000,000","$0","$1,800,000,000","2013","20131104","financial offenses","insider trading","","SAC Capital Advisors and related companies pleaded guilty to insider trading charges.","federal","agency action","U.S. Attorney-Southern District of New York","criminal","","","","","","","","","","","","USA","Connecticut","out of business","","financial services","hedge fund","https://www.justice.gov/usao-sdny/pr/manhattan-us-attorney-announces-guilty-plea-agreement-sac-capital-management-companies",""
